Silence Therapeutics (SLN) Short Interest
Nasdaq • SLN • US82686Q1013
As of Oct 26, 2026, ORTEX estimated 4.9% of free float sold short, 0.5 days to cover, cost to borrow 1.4%. Sign up for live short interest data.
Nasdaq • SLN • US82686Q1013
As of Oct 26, 2026, ORTEX estimated 4.9% of free float sold short, 0.5 days to cover, cost to borrow 1.4%. Sign up for live short interest data.
This page tracks how heavily Silence Therapeutics (Nasdaq:SLN) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Silence Therapeutics (Nasdaq: SLN) has a market capitalization of $1.23B. Last close $19.79 (as of 2026-11-11); 52-week range $4.19 to $19.87. ORTEX data as of 2026-10-26: short interest was 4.87% of free float, 0.5 days to cover and the average cost to borrow was 1.4%. Sign up for live short interest data.